SS
Sharad Shrikisan Zawar
About Sharad Shrikisan Zawar
Data last updated:
Sharad Shrikisan Zawar is a Director at Sanjeevani Criti-Care And Research Centre Private Limited (since 2007), Partner at Star Pathology Nashik Llp (since 2025) and Partner at Supreme Criticare And Research Center Llp (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Sanjeevani Criti-Care And Research Centre Private Limited at ₹2.78 Cr (FY 2024). Earlier, Sharad Shrikisan Zawar was a Director at Shree Balaji Research Centre & Hospital Private Limited (2008–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanjeevani Criti-Care And Research Centre Private Limited U85110MH2004PTC146533 | Director | 01 Dec 2007 | 2004 | ₹2.78 Cr (FY 2024) | Active |
| Star Pathology Nashik Llp AAP-6156 | Partner | 18 Feb 2025 | 2019 | Active | |
| Partner | 28 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Shree Balaji Research Centre & Hospital Private Limited U24233MH2007PTC168410 | Director | 15 Nov 2008 | 2007 | ₹10.9 Lakh (FY 2025) | Under Process Of Striking Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sharad Shrikisan Zawar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Archana Shekhar Somvanshi | 00930732 | Sanjeevani Criti-Care And Research Centre Private Limited | Director |
| Devendra Radhakrishna Deshpande | 01158389 | Sanjeevani Criti-Care And Research Centre Private Limited , Supreme Criticare And Research Center Llp | Director |
| Kiran Vishnusa Bhandge | 01281097 | Sanjeevani Criti-Care And Research Centre Private Limited | Director |
| Ravikiran Vishnu Nikam | 00931303 | Sanjeevani Criti-Care And Research Centre Private Limited , Star Pathology Nashik Llp and 1 more | Director |
| Sanket Suresh Sorate | 01161493 | Sanjeevani Criti-Care And Research Centre Private Limited , Supreme Criticare And Research Center Llp | Director |
| Shailendra Balkrishan Dadhich | 00930837 | Sanjeevani Criti-Care And Research Centre Private Limited | Director |
| Sanjeev Vasant Chaudhari | 08043478 | Star Pathology Nashik Llp | Designated Partner |
| Ajay Hiraman Wagh | 10609506 | Supreme Criticare And Research Center Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sharad Shrikisan Zawar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharad Shrikisan Zawar
Sharad Shrikisan Zawar currently holds 3 directorships: Sanjeevani Criti-Care And Research Centre Private Limited (Director, since 01 Dec 2007, revenue ₹2.78 Cr (FY 2024)); Star Pathology Nashik Llp (Partner, since 18 Feb 2025); Supreme Criticare And Research Center Llp (Partner, since 28 Apr 2024).
Sharad Shrikisan Zawar was first appointed on 01 Dec 2007 as Director at Sanjeevani Criti-Care And Research Centre Private Limited. The most recent appointment on record is 18 Feb 2025 at Star Pathology Nashik Llp.
Sharad Shrikisan Zawar held 1 earlier board appointment: Shree Balaji Research Centre & Hospital Private Limited (Director, 15 Nov 2008 to 25 Feb 2016).
The current boards of Sharad Shrikisan Zawar's companies include Archana Shekhar Somvanshi (Sanjeevani Criti-Care And Research Centre Private Limited), Devendra Radhakrishna Deshpande (Sanjeevani Criti-Care And Research Centre Private Limited), Kiran Vishnusa Bhandge (Sanjeevani Criti-Care And Research Centre Private Limited), Ravikiran Vishnu Nikam (Sanjeevani Criti-Care And Research Centre Private Limited), Sanket Suresh Sorate (Sanjeevani Criti-Care And Research Centre Private Limited), Shailendra Balkrishan Dadhich (Sanjeevani Criti-Care And Research Centre Private Limited), among others.